GlassScriptPhysician profile
Irene Machel
NPI 1538138953
$5,223.23
in general payments reported to CMS, 2019-2025
30 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $716 · 2020: $746 · 2021: $753 · 2022: $1,060 · 2023: $792 · 2024: $786 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,946.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $1,681.85 | 2019-2024 | Aveed |
| Abbvie INC. | $578.02 | 2019-2025 | |
| Janssen Biotech, INC. | $483.00 | 2019-2023 | Erleada |
| Endo USA, INC. | $405.91 | 2024-2025 | Aveed |
| Coloplast Corp | $358.87 | 2019-2025 | Speedicath, Porges Coloplast |
| Boston Scientific Corporation | $358.40 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700 |
| Astellas Pharma US INC | $181.55 | 2019-2023 | Xtandi, Myrbetriq |
| Teleflex LLC | $152.80 | 2024-2025 | Urolift, Barrigel |
| Bayer Healthcare Pharmaceuticals INC. | $114.44 | 2020-2022 | |
| Convatec INC. | $104.44 | 2020-2022 | |
| Medtronic, INC. | $102.40 | 2021-2024 | Interstim |
| Axonics, INC. | $84.85 | 2022-2024 | Axonics, Bulkamid |
| Blue Earth Diagnostics | $80.93 | 2019-2024 | |
| Olympus America INC. | $76.45 | 2022-2025 | Gyrus Acmi, Itind System |
| Rochester Medical Corporation | $66.32 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $62.28 | 2023 | Seglentis |
| Urogen Pharma, INC. | $49.79 | 2022-2023 | Jelmyto |
| Tolmar, INC. | $33.09 | 2024 | |
| Myovant Sciences INC. | $29.66 | 2021 | |
| 180 Medical, INC. | $28.99 | 2024 | |
| Merck Sharp & Dohme LLC | $23.27 | 2021 | |
| Foundation Medicine, INC. | $22.36 | 2021 | |
| Allergan, INC. | $21.94 | 2022 | |
| Seagen INC. | $20.57 | 2019 | |
| Pfizer INC. | $17.85 | 2019 | |
| Immunitybio, INC. | $17.79 | 2024 | |
| Novartis Pharmaceuticals Corporation | $17.27 | 2022 | |
| Urovant Sciences INC | $17.09 | 2022 | |
| Accord Healthcare, INC. | $15.96 | 2022 | |
| Dentsply Ih INC. | $15.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irene Machel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.